Atorvastatin Calcium Patent Expiration
Atorvastatin Calcium is used for reducing LDL-C levels in patients with homozygous familial hypercholesterolemia. It was first introduced by Upjohn Manufacturing Ireland Unltd
Atorvastatin Calcium Patents
Given below is the list of patents protecting Atorvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Atorvaliq | US11369567 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
| Atorvaliq | US11654106 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
| Atorvaliq | US11925704 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
| Atorvaliq | US12168069 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
| Lipitor |
US5969156 (Pediatric) | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jan 08, 2017
(Expired) | Upjohn |
| Lipitor | US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jul 08, 2016
(Expired) | Upjohn |
| Lipitor |
US5686104 (Pediatric) | Stable oral CI-981 formulation and process of preparing same |
May 11, 2015
(Expired) | Upjohn |
| Lipitor | US5686104 | Stable oral CI-981 formulation and process of preparing same |
Nov 11, 2014
(Expired) | Upjohn |
| Lipitor |
US6126971 (Pediatric) | Stable oral CI-981 formulation and process for preparing same |
Jul 19, 2013
(Expired) | Upjohn |
| Lipitor | US6126971 | Stable oral CI-981 formulation and process for preparing same |
Jan 19, 2013
(Expired) | Upjohn |
Atorvastatin Calcium's Family Patents
Explore Our Curated Drug Screens
Atorvastatin Calcium Generic API Manufacturers
Several generic applications have been filed for Atorvastatin Calcium. The first generic version for Atorvastatin Calcium was by Sun Pharmaceutical Industries Ltd and was approved on Nov 30, 2011. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jun 3, 2024.
Given below is the list of companies who have filed for Atorvastatin Calcium generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Mar 30, 2018 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Mar 30, 2018 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Mar 30, 2018 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Mar 30, 2018 |
2. AGNITIO
Agnitio Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Agnitio.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 2, 2021 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Sep 2, 2021 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Sep 2, 2021 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 2, 2021 |
Manufacturing Plant Locations New
Agnitio's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Agnitio as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Dec 21, 2018 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Dec 21, 2018 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Dec 21, 2018 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Dec 21, 2018 |
4. APOTEX INC
Apotex Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2024 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2024 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2024 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2024 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. BIOCON PHARMA
Biocon Pharma Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Biocon Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 23, 2022 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 23, 2022 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 23, 2022 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 23, 2022 |
Manufacturing Plant Locations New
Biocon Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Biocon Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
7. CADILA PHARMS LTD
Cadila Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2023 |
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2023 |
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2023 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2023 |
8. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
9. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jul 14, 2021 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 14, 2021 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jul 14, 2021 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jul 14, 2021 |
10. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2012 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2012 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2012 |
11. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jun 18, 2018 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jun 18, 2018 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jun 18, 2018 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jun 18, 2018 |
12. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2023 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2023 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2023 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2023 |
13. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 2017 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 2017 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 2017 |
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 2017 |
14. LANNETT CO INC
Lannett Co Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Apr 5, 2013 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Apr 5, 2013 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Apr 5, 2013 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Apr 5, 2013 |
15. LAURUS
Laurus Labs Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Laurus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 22, 2024 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jan 22, 2024 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 22, 2024 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jan 22, 2024 |
Manufacturing Plant Locations New
Laurus's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Laurus as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
16. LEPU PHARM
Lepu Pharmaceutical Technology Co Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Lepu Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Nov 3, 2022 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Nov 3, 2022 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Nov 3, 2022 |
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | Nov 3, 2022 |
17. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Mar 6, 2019 |
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | Mar 6, 2019 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Mar 6, 2019 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Mar 6, 2019 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
18. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jun 3, 2024 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jun 3, 2024 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jun 3, 2024 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jun 3, 2024 |
19. MANKIND PHARMA
Mankind Pharma Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jan 5, 2024 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jan 5, 2024 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 5, 2024 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 5, 2024 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
20. MICRO LABS LTD INDIA
Micro Labs Ltd India has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Micro Labs Ltd India.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2019 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2019 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2019 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 7, 2019 |
21. MSN
Msn Laboratories Private Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
Manufacturing Plant Locations New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||
| United States |
| |||||||||||||||||||||
22. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | May 29, 2012 |
23. PERRIGO R AND D
Perrigo R And D Co has filed for 2 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Jun 23, 2020 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jun 23, 2020 |
24. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | May 19, 2016 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 19, 2016 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | May 19, 2016 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | May 19, 2016 |
25. SHANDONG XINHUA
Shandong Xinhua Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Shandong Xinhua.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Jan 25, 2024 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jan 25, 2024 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jan 25, 2024 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Jan 25, 2024 |
Manufacturing Plant Locations New
Shandong Xinhua's manufacturing plants are situated in 2 countries - China, United States. Given below are the details of these plant locations as well as the firm names of Shandong Xinhua as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| China |
| |||||||
| United States |
| |||||||
26. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | Dec 21, 2023 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Dec 21, 2023 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Dec 21, 2023 |
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Dec 21, 2023 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
27. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2011 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2011 |
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2011 |
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2011 |
28. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Discontinued | ORAL | N/A | May 29, 2012 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | May 29, 2012 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | May 29, 2012 |
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | May 29, 2012 |
29. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2017 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2017 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2017 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2017 |
30. UMEDICA
Umedica Laboratories Private Ltd has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Umedica.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet | Prescription | ORAL | BX | Aug 19, 2020 |
| EQ 40MG BASE | tablet | Prescription | ORAL | BX | Aug 19, 2020 |
| EQ 20MG BASE | tablet | Prescription | ORAL | BX | Aug 19, 2020 |
| EQ 10MG BASE | tablet | Prescription | ORAL | BX | Aug 19, 2020 |
Manufacturing Plant Locations New
Umedica's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Umedica as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
31. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Atorvastatin Calcium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2018 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2018 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2018 |
| EQ 80MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2018 |